Effect of discontinuation of lemborexant following long‐term treatment of insomnia disorder: Secondary analysis of a randomized clinical trial

Discontinuing long‐term pharmacotherapy for insomnia can result in rebound insomnia or withdrawal symptoms and suboptimal treatment. Post hoc analyses evaluated rebound insomnia and withdrawal symptoms among the subset of subjects from a phase III, 12‐month, global, multicenter, randomized, double‐b...

Descripción completa

Detalles Bibliográficos
Autores principales: Takaesu, Yoshikazu, Suzuki, Masahiro, Moline, Margaret, Pinner, Kate, Inabe, Kanako, Nishi, Yurie, Kuriyama, Kenichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087073/
https://www.ncbi.nlm.nih.gov/pubmed/36564964
http://dx.doi.org/10.1111/cts.13470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087073/
https://www.ncbi.nlm.nih.gov/pubmed/36564964
http://dx.doi.org/10.1111/cts.13470

Ejemplares similares